Myeloid growth factors should not be administered routinely after allogeneic hematopoietic stem-cell transplantation [2] (multiple letters)

Jayesh Mehta*, Olle Ringdén

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)4429-4432
Number of pages4
JournalJournal of Clinical Oncology
Issue number21
StatePublished - Dec 1 2004

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this